Obese individuals with T2DM often exhibit dysregulated adipokine profiles, including reduced adiponectin and elevated resistin levels, along with increased concentrations of pro-inflammatory cytokines such as IL-6 and TNF-α [61,62]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.